Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm
Yao Wang,1 Amy Patel,1 Raymond S Douglas1,2 1Department of Surgery, Division of Ophthalmology, Cedars Sinai Medical Center, Los Angeles, CA, USA; 2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaCorrespondence...
Saved in:
Main Authors: | Wang Y (Author), Patel A (Author), Douglas RS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sight-Threatening Condition in Severe Thyroid Eye Disease: How We Should Manage
by: Yunia Irawati, et al.
Published: (2022) -
Graves' ophthalmopathy - thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019) -
Graves' ophthalmopathy - thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019) -
Changing the Paradigm for the Treatment and Development of New Therapies for FSGS
by: Cathie eSpino, et al.
Published: (2016) -
The thyroid eye disease (TED) laterality debate: A comparison of characteristics, presentation, severity, and activity, between unilateral and bilateral thyroid eye disease
by: Ronald Steven S. Medalle II, MD, MBA, et al.
Published: (2022)